Gastric Cancer

Maintenance therapy with proton pump inhibitors and risk of gastric cancer: A nationwide population-based cohort study in Sweden

BMJ Open | October 31, 2017 Brusselaers N, et al. – In Sweden, a nationwide population-based cohort study is performed to evaluate the risk of gastric cancer-related to proton pump inhibitor (PPI) use, considering underlying signs. The outcome suggests that the long-term PPI use might be an independent risk factor for gastric cancer. This challenges […]

A pooled analysis of dietary sugar/carbohydrate intake and esophageal and gastric cardia adenocarcinoma incidence and survival in the USA

International Journal of Epidemiology | September 26, 2017 Li N, et al. – This study assessed the impact of sugar/carbohydrate intake on the incidence and survival of US patients with esophageal/gastric cardia adenocarcinoma (EA/GCA). Researchers reported that if corroborated, limiting intake of sucrose (e.g. table sugar), sweetened desserts/beverages, and foods that contribute to a high […]

Aspirin and Cancer Prevention

Benefits Add Up for Regular Aspirin Use Published: Aug 5, 2014 | Updated: Aug 6, 2014 Discussant: Joseph Chao, MD. Average-risk adults in the general population who used aspirin regularly for at least 5 years had a lower risk of cancer, myocardial infarction (MI), stroke, and premature death, according to a comprehensive review of potential […]